Detalles de la búsqueda
1.
Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?
Oncology
; 2021 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34875670
2.
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial.
Int J Med Sci
; 18(10): 2245-2250, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33859534
3.
Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors.
Support Care Cancer
; 28(3): 1051-1058, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31177390
4.
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study.
Oncologist
; 24(6): e327-e337, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30796151
5.
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?
Future Oncol
; 13(30): 2791-2797, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29182361
6.
Topical Menthol for Treatment of Chemotherapy-induced Peripheral Neuropathy.
Indian J Palliat Care
; 23(3): 350-352, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28827946
7.
Dose-dense nonpegylated liposomal Doxorubicin and docetaxel combination in breast cancer: dose-finding study.
Oncologist
; 20(2): 109-10, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25601964
8.
Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer.
Biomedicines
; 12(1)2024 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38255284
9.
Role of Breast Cancer Risk Estimation Models to Identify Women Eligible for Genetic Testing and Risk-Reducing Surgery.
Biomedicines
; 12(4)2024 Mar 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38672070
10.
A method to comprehensively identify germline SNVs, INDELs and CNVs from whole exome sequencing data of BRCA1/2 negative breast cancer patients.
NAR Genom Bioinform
; 6(2): lqae033, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38633426
11.
Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx).
BMC Med
; 11: 59, 2013 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-23497191
12.
Role of the Molecular Tumor Board for the Personalized Treatment of Patients with Metastatic Breast Cancer: A Focus on the State of the Art in Italy.
Cancers (Basel)
; 15(6)2023 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980613
13.
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study.
Front Oncol
; 13: 1152123, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37260975
14.
Type 2 Diabetes Mellitus and Efficacy Outcomes from Immune Checkpoint Blockade in Patients with Cancer.
Clin Cancer Res
; 29(14): 2714-2724, 2023 07 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-37125965
15.
Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease.
BMC Med
; 10: 135, 2012 Nov 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-23136868
16.
Allostatic Load as an Insight into the Psychological Burden after Primary Treatment in Women with Breast Cancer: Influence of Physical Side Effects and Pain Perception.
J Clin Med
; 11(8)2022 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35456237
17.
Concurrent RAS and RAS/BRAF V600E Variants in Colorectal Cancer: More Frequent Than Expected? A Case Report.
Front Oncol
; 12: 863639, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35463316
18.
Anthracycline-Free Neoadjuvant Treatment in Patients with HER2-Positive Breast Cancer: Real-Life Use of Pertuzumab, Trastuzumab and Taxanes Association with an Exploratory Analysis of PIK3CA Mutational Status.
Cancers (Basel)
; 14(12)2022 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35740668
19.
NSCLC Immunotherapy and Related Rare Toxicities: A Monocentric Real-Life Experience.
Cancer Med J
; 4(3): 115-119, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34746934
20.
Digital Innovation in Oncological Primary Treatment for Well-Being of Patients: Psychological Caring as Prompt for Enhancing Quality of Life.
Curr Oncol
; 28(4): 2452-2465, 2021 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34287251